◆ 會議時間：2026年6月11-14日
◆ 會議地點：瑞典 斯德哥爾摩
◆ 會議簡介：
2026年第31屆歐洲血液學大會/年會(31st EHA Congress)將于2026年6月11-14日在瑞典斯德哥爾摩市舉行，會議由歐洲血液學會(EHA)主辦。歐洲血液年會(EHA年會)是全球血液學領域規模最大的國際會議之一，于每年的6月在歐洲一個主要城市舉行。EHA大會主題涵蓋了血液學研究的各個面，每年都有來自全球100多個國家的10000余名專業人士與會，一起分享探討有關血液學的創新理念及宣最新的科學和臨床研究成果。EHA大會的目標是提高與會者對血液病診斷和治療的循證醫學知識；了解血液學及其亞專科的最新創新技術、診斷工具和風險評估策略；與眾多國際代表——醫學專業人員、各國血液學會、患者團體、醫療行業和媒體——溝通、協作和聯絡。會議數字（EHA2019與會人數：12614人，其中中國與會者：546人）
歐洲血液學協會(EHA)成立于1992年，是致力于促進血液學臨床實踐、研究和教育的非營利性組織，是國際上最大的血液學知識獨立提供商之一，目前在全球100多個國家擁有超過4500名成員，是歐洲最大的血液學組織。——未經本站許可，禁止復制轉載摘錄鏡像本站任何內容-領域國際醫學會議網。
EHA2026 Congress - 31st European Hematology Association (EHA) Congress
Date:
June 11 - 14, 2026
Venue:
Stockholm, Sweden
下為上屆信息
EHA2025 Congress - 30th European Hematology Association (EHA) Congress
Date:
June 12 - 15, 2025
Venue:
Allianz MiCo, Milano Convention Centre
Milan, Italy
Join us for the 30th EHA Congress, taking place from June 12-15, 2025, as we revolutionize the way we learn and connect in Hematology! Our team has worked tirelessly to reimagine the Congress experience, introducing innovative features that will transform your learning journey.
Say goodbye to traditional formats and hello to a more dynamic and engaging program, featuring Satellite Symposia and Updates-in-Hematology sessions, generously sponsored by leading organizations. Enjoy a more streamlined schedule, with strategically placed Plenary Sessions throughout the Congress days.
With an increased focus on invited speakers and a second poster session, we're thrilled to showcase the latest groundbreaking research. Our revised program ensures a balanced mix of scientific content, with fewer parallel sessions to minimize information overload.
At EHA2025, we're committed to creating an unforgettable experience that fosters connections, sparks innovation, and accelerates progress. Don't miss this opportunity to be at the forefront of the field!
重要日期：
| Date |
Deadline |
| 2025 January 1 |
Open Abstract submission & Travel/participation grant application
-
摘要征文投稿開始
|
| 2025 March 1 (23:59 CET) |
Deadline for abstract submission & travel/participation grant application - 摘要征文投稿截止 |
| 2025 April 24 (by) |
Announcement allocation of abstracts to authors |
| 2025 May 1 (23:59 CEST) |
Withdrawal deadline (regular abstracts) |
| 2025 May 2 |
Open Late-breaking abstract submission |
| 2025 May 9; 09:00 (CEST) |
Deadline Late-breaking abstract submission |
| 2025 May 14, 15:30 (CEST) |
Accepted abstracts available online |
| 2025 May 23 (by) |
Announcement allocation of late-breaking abstracts to authors |
| 2025 June 3; 15:30 (CEST) |
Accepted late-breaking abstracts available online |
點此提交摘要>>>Submit Abstract>>>
Submission specifications
Please find below some important specifications related to abstracts:
- Title count:?max. 200 characters incl. space.
- Character limit:?3500 characters.?The image is not included in the character count.
- One image per abstract is allowed. Image has to be included in JPG or PNG:?
- Width: min. 1 pixel / max. 500 pixels
- Heights: min. 1 pixel / max. 500 pixels
- Size: min. 1kb / max. 1000kb
- Resolution: min. 1 dpi / 600 dpi
- Authors: There is no limit to the number of authors.
Abstract topics
- Acute lymphoblastic leukemia - Biology & translational research?
- Acute lymphoblastic leukemia - Clinical?
- Acute myeloid leukemia - Biology & translational research?
- Acute myeloid leukemia - Clinical?
- Chronic lymphocytic leukemia and related disorders - Biology & translational research?
- Chronic lymphocytic leukemia and related disorders - Clinical?
- Chronic myeloid leukemia - Biology & translational research?
- Chronic myeloid leukemia - Clinical?
- Myelodysplastic syndromes - Biology & translational research?
- Myelodysplastic syndromes - Clinical?
- Bone marrow failure syndromes incl. PNH - Biology & translational research?
- Bone marrow failure syndromes incl. PNH - Clinical?
- Myeloma and other monoclonal gammopathies - Biology & translational research?
- Myeloma and other monoclonal gammopathies - Clinical?
- Myeloproliferative neoplasms - Biology & translational research?
- Myeloproliferative neoplasms - Clinical?
- Hodgkin lymphoma - Clinical?
- Indolent and mantle-cell non-Hodgkin lymphoma - Clinical?
- Aggressive non-Hodgkin lymphoma - Clinical?
- Lymphoma biology & translational research?
- Stem cell transplantation - Experimental?
- Stem cell transplantation - Clinical?
- Hematopoiesis, stem cells and microenvironment?
- Gene therapy, cellular immunotherapy and vaccination - Biology & translational research?
- Gene therapy, cellular immunotherapy and vaccination - Clinical?
- Sickle cell disease?
- Thalassemias?
- Enzymopathies, membranopathies and other anemias?
- Iron metabolism, deficiency and overload?
- Infections in hematology (incl. supportive care/therapy)?
- Transfusion medicine?
- Platelet disorders?
- Bleeding disorders (congenital and acquired)?
- Thrombosis and vascular biology?
- Quality of life and palliative care?
- Ethics and health economics?
- Novel technologies, techniques and digital analytical tools in hematology
EHA2025 注冊費：
EHA2025 registration fees
? |
Hybrid registration |
? |
Virtual only registration |
? |
Early |
Regular |
Late |
Early |
Regular |
Late |
? |
Ends May 2, 2025, 23:59 (CEST) |
Ends June 1, 2025, 23:59 (CEST) |
Ends June 15, 2025, 13:00 (CEST) |
Ends May 2, 2025, 23:59 (CEST) |
Ends June 1, 2025, 23:59 (CEST) |
Ends June 30, 2025 |
EHA Member |
?€439 |
?€599 |
?€659 |
?€219 |
?€299 |
?€329 |
Junior EHA Member* |
?€119 |
?€159 |
?€199 |
?€59 |
?€79 |
?€99 |
Non-member (junior & regular)? |
€769 |
€939 |
€1,029 |
€439 |
€519 |
€569 |
All fees are inclusive of VAT.?After May 2, 2025 only credit card payments are accepted.
* Participants born in 1988 or after.
EHA2025?Congress?|
June 12 - 15, 2025
EHA 2025-歐洲血液學年會-2025歐洲EHA血液年會-2025eha會議-歐洲血液年會-EHA血液學大會
◆ 參會對象：醫生、醫院科室主任/副主任、住院醫師、醫院管理者、醫護人員以及從事該領域研究的科學家、研究人員、醫藥企業代表等等。
|
